A Cluster Randomized Trial of an Enhanced eGFR Prompt in Chronic Kidney Disease
Authors:
- Braden MannsBMBraden Manns
- Marcello TonelliMTMarcello Tonelli
- Bruce CulletonBCBruce Culleton
- Peter FarisPFPeter Faris
- Kevin McLaughlinKMKevin McLaughlin
- Rick ChinRCRick Chin
- Katherine GoochKGKatherine Gooch
- Finlay A. McAlisterFMFinlay A. McAlister
- Ken TaubKTKen Taub
- Laurel ThorlaciusLTLaurel Thorlacius
- Richard KrauseRKRichard Krause
- Monica KearnsMKMonica Kearns
- 1 April 2012
- journal article
- research article
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 7 (4) , 565-572
Abstract
Summary: Background and objectives: Despite reporting estimated GFR (eGFR), use of evidence-based interventions in CKD remains suboptimal. This study sought to determine the effect of an enhanced eGFR laboratory prompt containing specific management recommendations, compared with standard eGFR reporting in CKD. Design, setting, participants, & measurements: A cluster randomized trial of a standard or enhanced eGFR laboratory prompt was performed in 93 primary care practices in Alberta, Canada. Although all adult patients with CKD (eGFR 2) were included, medication data were only available for elderly patients (aged ≥66 years). The primary outcome, the proportion of patients with diabetes or proteinuria receiving an angiotensin converting enzyme inhibitor (ACEi) or angiotensin receptor blocker (ARB), was assessed in elderly CKD patients. Results: There were 5444 elderly CKD patients with diabetes or proteinuria who were eligible for primary outcome assessment, irrespective of baseline ACEi/ARB use. ACEi/ARB use in the subsequent year was 77.1% and 76.9% in the standard and enhanced prompt groups, respectively. In the subgroup of elderly patients with an eGFR 2, ACEi/ARB use was higher in the enhanced prompt group. Among 22,092 CKD patients, there was no difference in the likelihood of a composite clinical outcome (death, ESRD, doubling of serum creatinine, or hospitalization for myocardial infarction, heart failure, or stroke) over a median of 2.1 years. Conclusions: In elderly patients with CKD and an indication for ACEi/ARB, an enhanced laboratory prompt did not increase use of these medications.Keywords
This publication has 40 references indexed in Scilit:
- Effect of point-of-care computer reminders on physician behaviour: a systematic reviewCanadian Medical Association Journal, 2010
- Validation of a Case Definition to Define Hypertension Using Administrative DataHypertension, 2009
- The Enhancing Secondary Prevention in Coronary Artery Disease trialCanadian Medical Association Journal, 2009
- Overview of the Alberta Kidney Disease NetworkBMC Nephrology, 2009
- Guidelines for the management of chronic kidney diseaseCanadian Medical Association Journal, 2008
- Electronic Health Records in Ambulatory Care — A National Survey of PhysiciansNew England Journal of Medicine, 2008
- Multifaceted intervention to improve diagnosis and treatment of osteoporosis in patients with recent wrist fracture: a randomized controlled trialCanadian Medical Association Journal, 2008
- Effects of Computerized Clinical Decision Support Systems on Practitioner Performance and Patient OutcomesJAMA, 2005
- Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and HospitalizationNew England Journal of Medicine, 2004
- Longitudinal data analysis using generalized linear modelsBiometrika, 1986